Literature DB >> 29037082

The D313Y variant in the GLA gene - no evidence of a pathogenic role in Fabry disease.

Lis Hasholt1, Martin Ballegaard2, Henning Bundgaard3, Michael Christiansen4, Ian Law5, Allan M Lund6, Anne Norremolle1, Ase Krogh Rasmussen7, Kirstine Ravn6, Zeynep Tumer1, Flemming Wibrand6, Ulla Feldt-Rasmussen7.   

Abstract

Fabry disease is an X- linked inherited lysosomal storage disease caused by mutations in the GLA gene encoding the lysosomal enzyme alpha-galactosidase A (α-Gal A). The possible pathological significance of the D313Y variant in the GLA gene has not been verified and it may be a Fabry variant. Our aim was to elucidate whether the presence of the D313Y variant influenced the α-Gal A activity or resulted in Fabry symptoms or Fabry organ involvement. In two Danish families the presence of the D313Y variant did not result in reduced α-Gal A activity or clinical Fabry manifestations in males, and the presence in Fabry females did not significantly enhance the phenotype of a known causative mutation in the GLA gene (G271S). Our findings indicate that the D313Y variant is not causative to nor enhancing Fabry disease phenotype. The D313Y variant in the GLA gene was not disease causative in 2 Danish families. Investigating male family members were crucial in excluding the Fabry phenotype, and thus very important for proper genetic counceling of all family members, as well as overdiagnosing a devastating genetic disease.

Entities:  

Keywords:  D313Y; Fabry disease; genetic councelling; genetic variant; α GAL A activity

Mesh:

Substances:

Year:  2017        PMID: 29037082     DOI: 10.1080/00365513.2017.1390782

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  4 in total

1.  GLA missense and promoter variants co-segregating in a Chinese family with Fabry disease.

Authors:  Zhe-Yi Dong; Qian Wang; Shu-Peng Lin; Pu Chen; Jiao-Na Liu; Shu-Wen Liu; Guang-Yan Cai; Xiang-Mei Chen; Quan Hong
Journal:  Ann Transl Med       Date:  2020-07

2.  Correlation between GLA variants and alpha-Galactosidase A profile in dried blood spot: an observational study in Brazilian patients.

Authors:  Patrícia Varela; Gianna Mastroianni Kirsztajn; Fabiana L Motta; Renan P Martin; Lauro T Turaça; Henrique L F Ferrer; Caio P Gomes; Priscila Nicolicht; Maryana Mara Marins; Juliana G Pessoa; Marion C Braga; Vânia D'Almeida; Ana Maria Martins; João B Pesquero
Journal:  Orphanet J Rare Dis       Date:  2020-01-29       Impact factor: 4.123

3.  Dorsal root ganglia volume is increased in patients with the Fabry-related GLA variant p.D313Y.

Authors:  Tim Godel; Philipp Bäumer; Katharina Stumpfe; Nicole Muschol; Moritz Kronlage; Merle Brunnée; Jennifer Kollmer; Sabine Heiland; Martin Bendszus; Victor-Felix Mautner
Journal:  J Neurol       Date:  2019-03-04       Impact factor: 4.849

4.  Prevalence of Fabry Disease among Patients with Parkinson's Disease.

Authors:  Alexandra Lackova; Christian Beetz; Sebastian Oppermann; Peter Bauer; Petra Pavelekova; Tatiana Lorincova; Miriam Ostrozovicova; Kristina Kulcsarova; Jana Cobejova; Martin Cobej; Petra Levicka; Simona Liesenerova; Daniela Sendekova; Viktoria Sukovska; Zuzana Gdovinova; Vladimir Han; Mie Rizig; Henry Houlden; Matej Skorvanek
Journal:  Parkinsons Dis       Date:  2022-01-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.